Literature DB >> 21856102

Contrast media safety-an update.

Henrik S Thomsen1.   

Abstract

The value of contrast agents has for long been documented by their common daily use in imaging departments worldwide. In principle, they should be injected and leave the body immediately after use in the same condition or undergo natural metabolism without making any harm to the patient. However, this is not the case. It is of utmost importance to reduce the prevalence to as close as possible to zero. This can be done by identifying the patients at risk before administration of contrast agents. For acute non-renal adverse reactions, it is also important to be prepared for treating them instantly. The current review is a short state of the art regarding adverse reactions to contrast agents.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856102     DOI: 10.1016/j.ejrad.2010.12.104

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Percutaneous Coronary Intervention for Chronic Total Occlusion versus Percutaneous Coronary Intervention for Non-Complex Coronary Lesions: Is There a Different Impact on Thyroid Function?

Authors:  Çağın Mustafa Üreyen; Kahraman Coşansu; Mustafa Gökhan Vural; Sait Emir Şahin; Mehmet Akif Çakar; Harun Kılıç; Mustafa Tarık Ağaç; Hüseyin Gündüz; Ramazan Akdemir; Ersan Tatlı
Journal:  Med Princ Pract       Date:  2019-09-20       Impact factor: 1.927

2.  Influence of field strength, coil type and image resolution on assessment of synovitis by unenhanced MRI--a comparison with contrast-enhanced MRI.

Authors:  Iris Eshed; Simon Krabbe; Mikkel Østergaard; Pernille Bøyesen; Jakob M Møller; Flemming Therkildsen; Ole Rintek Madsen; Mette Axelsen; Susanne Juhl Pedersen
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

3.  Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.

Authors:  Bronwyn E Hamilton; Ramon Barajas; Gary M Nesbit; Rongwei Fu; Prakash Ambady; Matthew Taylor; Edward A Neuwelt
Journal:  AJR Am J Roentgenol       Date:  2020-10-14       Impact factor: 3.959

4.  Can a structured questionnaire identify patients with reduced renal function?

Authors:  Manal Azzouz; Janne Rømsing; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2013-11-26       Impact factor: 5.315

5.  The Effectiveness of Automatic Recommending System for Premedication in Reducing Recurrent Radiocontrast Media Hypersensitivity Reactions.

Authors:  Yun-Jeong Bae; Ye Won Hwang; Sun-Young Yoon; Sujeong Kim; Taehoon Lee; Yoon Su Lee; Hyouk-Soo Kwon; You Sook Cho; Myung Jin Shin; Hee-Bom Moon; Tae-Bum Kim
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

6.  EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision.

Authors:  Hein J Verberne; Wanda Acampa; Constantinos Anagnostopoulos; Jim Ballinger; Frank Bengel; Pieter De Bondt; Ronny R Buechel; Alberto Cuocolo; Berthe L F van Eck-Smit; Albert Flotats; Marcus Hacker; Cecilia Hindorf; Philip A Kaufmann; Oliver Lindner; Michael Ljungberg; Markus Lonsdale; Alain Manrique; David Minarik; Arthur J H A Scholte; Riemer H J A Slart; Elin Trägårdh; Tim C de Wit; Birger Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-21       Impact factor: 9.236

Review 7.  Radiographic and magnetic resonances contrast agents: Essentials and tips for safe practices.

Authors:  Mohamed R Nouh; Mohamed A El-Shazly
Journal:  World J Radiol       Date:  2017-09-28

8.  The feasibility of deep learning-based synthetic contrast-enhanced CT from nonenhanced CT in emergency department patients with acute abdominal pain.

Authors:  Se Woo Kim; Jung Hoon Kim; Suha Kwak; Minkyo Seo; Changhyun Ryoo; Cheong-Il Shin; Siwon Jang; Jungheum Cho; Young-Hoon Kim; Kyutae Jeon
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

9.  Stable aqueous dispersion of superparamagnetic iron oxide nanoparticles protected by charged chitosan derivatives.

Authors:  Agnieszka Szpak; Gabriela Kania; Tomasz Skórka; Waldemar Tokarz; Szczepan Zapotoczny; Maria Nowakowska
Journal:  J Nanopart Res       Date:  2012-12-22       Impact factor: 2.253

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.